The developer of high-affinity monoclonal antibodies for applications in clinical diagnostics, announced fantastic audited results for the year ended 30 June 2015. Pre-tax margins of over 70% and superb cash…
Bioventix is a business engaged in the creation and engineering of antibodies. It was incorporated in 2003, and began trading on PLUS Market in 2010, before moving to AIM in…
Search for AIM companies qualifying for relief from Inheritance Tax!
Use our unique screening tool to identify Inheritance Tax planning AIM companies
This search will take you to the separate AIMsearch web site which requires a different user name and password to this Investor's Champion site.
Investor's Champion, the small cap specialist, provides expert research on smaller quoted companies.
ABOUT INVESTORS CHAMPION
Investor's Champion offers objective, incisive and forthright comment on quoted companies. Our commentaries address what we believe are the key issues in respect of each company in a concise easy to read format.
Investor's Champion is a registered trade mark of Investors Champion Ltd. Investor's Champion Limited is a company registered in England and Wales under number 03577867 whose registered office is at Fourth & Fifth Floor, 14-15 Lower Grosvenor Place, London, England, SW1W 0EX.